These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 7983595)
21. Salt screening and characterization for poorly soluble, weak basic compounds: case study albendazole. Paulekuhn GS; Dressman JB; Saal C Pharmazie; 2013 Jul; 68(7):555-64. PubMed ID: 23923637 [TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical relationships of three solid state forms of stavudine. Gandhi RB; Bogardus JB; Bugay DE; Perrone RK; Kaplan MA Int J Pharm; 2000 May; 201(2):221-37. PubMed ID: 10878328 [TBL] [Abstract][Full Text] [Related]
24. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898 [TBL] [Abstract][Full Text] [Related]
25. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form. Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784 [TBL] [Abstract][Full Text] [Related]
26. Polymorphs of DP-VPA Solid Solutions and Their Physicochemical Properties. Hao C; Jin J; Xiong J; Yang Z; Gao L; Ma Y; Liu BF; Liu X; Chen Y; Zhang G J Pharm Sci; 2020 Jul; 109(7):2156-2165. PubMed ID: 32240697 [TBL] [Abstract][Full Text] [Related]
28. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process. Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. Grzesiak AL; Lang M; Kim K; Matzger AJ J Pharm Sci; 2003 Nov; 92(11):2260-71. PubMed ID: 14603511 [TBL] [Abstract][Full Text] [Related]
33. Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization. Tong HH; Wu HB; Zheng Y; Xi J; Chow AH; Chan CK Int J Pharm; 2008 May; 355(1-2):195-202. PubMed ID: 18207676 [TBL] [Abstract][Full Text] [Related]
34. Progressive steps of polymorphic transformation of gabapentin polymorphs studied by hot-stage FTIR microspectroscopy. Hsu CH; Ke WT; Lin SY J Pharm Pharm Sci; 2010; 13(1):67-77. PubMed ID: 20456832 [TBL] [Abstract][Full Text] [Related]
35. Physicochemical characterization of a new respirable form of nedocromil. Chan HK; Gonda I J Pharm Sci; 1995 Jun; 84(6):692-6. PubMed ID: 7562406 [TBL] [Abstract][Full Text] [Related]
36. Physicochemical characterization of deflazacort: thermal analysis, crystallographic and spectroscopic study. Cuffini SL; Ellena JF; Mascarenhas YP; Ayala AP; Sielser HW; Filho JM; Monti GA; Aiassa V; Sperandeo NR Steroids; 2007 Mar; 72(3):261-9. PubMed ID: 17207826 [TBL] [Abstract][Full Text] [Related]
37. Physicochemical characterization of 9,10-anthraquinone 2-carboxylic acid. Tsai SY; Kuo SC; Lin SY J Pharm Sci; 1993 Dec; 82(12):1250-4. PubMed ID: 8308705 [TBL] [Abstract][Full Text] [Related]
38. Studies on the crystal forms of pefloxacin: preparation, characterization, and dissolution profile. Yadav MR; Shaikh AR; Ganesan V; Giridhar R; Chadha R J Pharm Sci; 2008 Jul; 97(7):2637-48. PubMed ID: 17854073 [TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of metastable solid-state forms of lopinavir. Lemmer HJ; Liebenberg W Pharmazie; 2013 May; 68(5):327-32. PubMed ID: 23802429 [TBL] [Abstract][Full Text] [Related]
40. Physicochemical characterization of glybuzole polymorphs and their pharmaceutical properties. Otsuka M; Ofusa T; Matsuda Y Drug Dev Ind Pharm; 1999 Feb; 25(2):197-203. PubMed ID: 10065353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]